Question 1

What is InterCure Ltd (INCR)?

Accepted Answer

InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets. It operates in the Healthcare sector.

InterCure Ltd is a good buy right now due to its current price of 5.78, a significant 5-day change of +35.76%, and strong financial backing from a recent settlement of approximately $77 million. The main risk is its negative 1-year change of -29.08%, indicating past performance issues that investors should consider.

12 analysts cover INCR: 8 rate it Buy, 4 Hold and 0 Sell.

Question 2

Should I buy INCR?

Accepted Answer

InterCure Ltd is a good buy right now due to its current price of 5.78, a significant 5-day change of +35.76%, and strong financial backing from a recent settlement of approximately $77 million. The main risk is its negative 1-year change of -29.08%, indicating past performance issues that investors should consider.